231 related articles for article (PubMed ID: 36458585)
1. Iron oxide nanoparticle targeting mechanism and its application in tumor magnetic resonance imaging and therapy.
Wu L; Wang C; Li Y
Nanomedicine (Lond); 2022 Sep; 17(21):1567-1583. PubMed ID: 36458585
[TBL] [Abstract][Full Text] [Related]
2. Surface engineering of magnetic iron oxide nanoparticles by polymer grafting: synthesis progress and biomedical applications.
Hou Z; Liu Y; Xu J; Zhu J
Nanoscale; 2020 Jul; 12(28):14957-14975. PubMed ID: 32648868
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-controllable iron oxide nanoparticle assemblies: Design, manipulation and bio-applications.
Low LE; Lim HP; Ong YS; Siva SP; Sia CS; Goh BH; Chan ES; Tey BT
J Control Release; 2022 May; 345():231-274. PubMed ID: 35306119
[TBL] [Abstract][Full Text] [Related]
4. Iron Oxide Nanoparticles: Physicochemical Characteristics and Historical Developments to Commercialization for Potential Technological Applications.
Etemadi H; Buchanan JK; Kandile NG; Plieger PG
ACS Biomater Sci Eng; 2021 Dec; 7(12):5432-5450. PubMed ID: 34786932
[TBL] [Abstract][Full Text] [Related]
5. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.
Ahmed MSU; Salam AB; Yates C; Willian K; Jaynes J; Turner T; Abdalla MO
Int J Nanomedicine; 2017; 12():6973-6984. PubMed ID: 29033565
[TBL] [Abstract][Full Text] [Related]
6. Iron oxide nanoparticles for biomedical applications: an updated patent review (2015-2021).
Mao Z; Li X; Wang P; Yan H
Expert Opin Ther Pat; 2022 Sep; 32(9):939-952. PubMed ID: 35929879
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres.
Kucharczyk K; Kaczmarek K; Jozefczak A; Slachcinski M; Mackiewicz A; Dams-Kozlowska H
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111654. PubMed ID: 33545822
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Iron Oxide Nanoparticle (IONP) Synthesis to Applications: Present and Future.
Ajinkya N; Yu X; Kaithal P; Luo H; Somani P; Ramakrishna S
Materials (Basel); 2020 Oct; 13(20):. PubMed ID: 33080937
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant Iron Oxide Nanoparticles: Their Biocompatibility and Bioactive Properties.
Lee J; Lee JH; Lee SY; Park SA; Kim JH; Hwang D; Kim KA; Kim HS
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958885
[TBL] [Abstract][Full Text] [Related]
10. Imaging the distribution of iron oxide nanoparticles in hypothermic perfused tissues.
Ring HL; Gao Z; Sharma A; Han Z; Lee C; Brockbank KGM; Greene ED; Helke KL; Chen Z; Campbell LH; Weegman B; Davis M; Taylor M; Giwa S; Fahy GM; Wowk B; Pagotan R; Bischof JC; Garwood M
Magn Reson Med; 2020 May; 83(5):1750-1759. PubMed ID: 31815324
[TBL] [Abstract][Full Text] [Related]
11. Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles.
Xu Y; Wu H; Huang J; Qian W; Martinson DE; Ji B; Li Y; Wang YA; Yang L; Mao H
Theranostics; 2020; 10(6):2479-2494. PubMed ID: 32194814
[No Abstract] [Full Text] [Related]
12. Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications.
Frtús A; Smolková B; Uzhytchak M; Lunova M; Jirsa M; Kubinová Š; Dejneka A; Lunov O
J Control Release; 2020 Dec; 328():59-77. PubMed ID: 32860925
[TBL] [Abstract][Full Text] [Related]
13. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.
Hadjipanayis CG; Machaidze R; Kaluzova M; Wang L; Schuette AJ; Chen H; Wu X; Mao H
Cancer Res; 2010 Aug; 70(15):6303-12. PubMed ID: 20647323
[TBL] [Abstract][Full Text] [Related]
14. [Development of Molecular Probes Based on Iron Oxide Nanoparticles for in Vivo Magnetic Resonance/Photoacoustic Dual Imaging of Target Molecules in Tumors].
Sano K
Yakugaku Zasshi; 2017; 137(1):55-60. PubMed ID: 28049896
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in iron oxide nanoparticles for brain cancer theranostics: from
Sheervalilou R; Shirvaliloo M; Sargazi S; Ghaznavi H
Expert Opin Drug Deliv; 2021 Jul; 18(7):949-977. PubMed ID: 33567919
[No Abstract] [Full Text] [Related]
16. The effect of mechanical properties of iron oxide nanoparticle-loaded functional nano-carrier on tumor targeting and imaging.
Choi WI; Kim JY; Heo SU; Jeong YY; Kim YH; Tae G
J Control Release; 2012 Sep; 162(2):267-75. PubMed ID: 22824783
[TBL] [Abstract][Full Text] [Related]
17. Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances.
Hola K; Markova Z; Zoppellaro G; Tucek J; Zboril R
Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1162-76. PubMed ID: 25689073
[TBL] [Abstract][Full Text] [Related]
18. Multimodal Composite Iron Oxide Nanoparticles for Biomedical Applications.
Pillarisetti S; Uthaman S; Huh KM; Koh YS; Lee S; Park IK
Tissue Eng Regen Med; 2019 Oct; 16(5):451-465. PubMed ID: 31624701
[TBL] [Abstract][Full Text] [Related]
19. PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging.
Shi J; Yu X; Wang L; Liu Y; Gao J; Zhang J; Ma R; Liu R; Zhang Z
Biomaterials; 2013 Dec; 34(37):9666-77. PubMed ID: 24034498
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration.
Aboushoushah S; Alshammari W; Darwesh R; Elbaily N
Life Sci; 2021 Jul; 277():119625. PubMed ID: 34015288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
